rosuvastatin

(redirected from Crestor)
Also found in: Medical.

ro·su·va·stat·in

 (rŏ-so͞o′və-stăt′n)
n.
A statin drug, C22H28FN3O6S, used in the form of its calcium salt to lower cholesterol (especially LDL) levels and to reduce the risk of heart attack and stroke in individuals with elevated risk.

[Perhaps (fluo)ro- + su(lfonyl) + -vastatin, statin suffix; see pravastatin.]
Translations

rosuvastatin

n rosuvastatina
References in periodicals archive ?
Pharmaceutical firm AstraZeneca (LSE:AZN) has seen a 13% decrease in its fourth-quarter revenue after its cholesterol treatment, Crestor, lost patent protection in the United States.
6 billion) in the three months to September 30, as its top-selling drug took a hit from the launch of a number of Crestor generic medicines.
Pre-tax profits slipped 27% to $676m (PS544m) over the period, as sales of Crestor and Nexium dropped by 82% and 50% respectively.
WASHINGTON -- A federal judge has refused to issue a temporary restraining order blocking approval of new generic versions of AstraZeneca's blockbuster cholesterol drug Crestor in the United States.
Food and Drug Administration today approved the first generic version of Crestor (rosuvastatin calcium) tablets for the following uses: in combination with diet for the treatment of high triglycerides (hypertriglyceridemia) in adults; in combination with diet for treatment of patients with primary dysbetalipoproteinemia (Type III Hyperlipoproteinemia), a disorder associated with improper breakdown of cholesterol and triglycerides; either alone or in combination with other cholesterol treatment(s) for adult patients with homozygous familial hypercholesterolemia, a disorder associated with high low-density lipoprotein (LDL) cholesterol.
The British-based group is working on a fixed-dose combination of Crestor and Epanova that, if successful, would extend the Crestor franchise beyond 2016, when the drug's U.
In the short term, AstraZeneca's share is expected to be driven by news around cholesterol-lowering drug Crestor and blood thinner Brilinta.
ASTRAZENECA posted better-than-expected profits yesterday as key brands such as cholesterol product Crestor helped it weather testing conditions.
Patients taking AstraZeneca Plc's (London GBR) cholesterol-lowering medicine Crestor in a study were less likely to develop pneumonia, a finding that potentially will broaden use of such drugs.
SHARES in pharmaceuticals giant AstraZeneca rocketed after it won a three-year battle over its Crestor cholesterol drug which will keep cheap rivals at bay in the US until 2016.
PHARMACEUTICALS giant AstraZeneca saw its shares rocket after it won a three-year battle over its Crestor cholesterol drug which will keep cheap rivals at bay in the US until 2016.
Statin drugs such as Crestor, Lipitor, Pravachol and Zocor were initially formulated to reduce LDL cholesterol.